Svastia Genetics is a San Francisco-based company that specializes in precision medicines and utilizes multi-omics to enhance pharmaceutical research and development. Their clinical-genomic platform offers personalized genetic screening for cancer patients, enabling doctors to select the most suitable therapy or refer patients to relevant clinical trials based on their genetic profiles.
With a focus on next-generation sequencing breakthroughs, Svastia provides a range of products and services for pharmaceutical research, including drug efficacy screening, patient selection for clinical trials, and pre-clinical drug development programs. They also offer a unified platform that connects various service providers, ensuring quality and timely delivery of their bundled experiments and bioinformatics. With a team of experienced professionals and partnerships with hospitals and research organizations, Svastia Genetics aims to de-risk preclinical and clinical development through data-driven research collaborations.
Generated from the website